ZIOPHARM Oncology IncZIOPHARM Oncology Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The webpage is a free Environmental, Social and Governance analysis for ZIOPHARM Oncology Inc. This ESG rating for ZIOPHARM Oncology Inc indicates its reporting of the UN Sustainable Development Goals. The ESG score covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Life on Land'.

ZIOPHARM Oncology Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 4.8, social score of 1.6 and governance score of 5.3.

SDG Transparency Score for ZIOPHARM Oncology Inc 

3.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for ZIOPHARM Oncology Inc 
4.8

Environmental

1.6

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1443XSpray Pharma AB (publ)
4.0
High
1443Zhong Yuan Bio-Technology Holdings Ltd
4.0
High
.........
1476ZIOPHARM Oncology Inc
3.9
Medium
1476Anebulo Pharmaceuticals Inc
3.9
Medium
1476Anhui Sunhere Pharmaceutical Excipients Co Ltd
3.9
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does ZIOPHARM Oncology Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc report the average age of the workforce?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc offer flexible work?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc conduct supply chain audits?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose water use targets?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did ZIOPHARM Oncology Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has ZIOPHARM Oncology Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is ZIOPHARM Oncology Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose its waste policy?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose energy use targets?

LockedSign up for free to unlock

Does ZIOPHARM Oncology Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does ZIOPHARM Oncology Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for ZIOPHARM Oncology Inc
These potential risks are based on the size, segment and geographies of the company.

ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chimeric antigen receptor + T cell therapies targeting CD19 for hematologic malignancies; and Ad-RTS-hIL-12 plus veledimex, a gene delivery system to regulate production of IL-12 to treat patients with recurrent glioblastoma multiforme in adults. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; a patent license agreement with the National Cancer Institute; and a cooperative research and development agreement with the National Cancer Institute. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts.

Sorry!

Failed to process!